Registry of Coronary Artery Ill Patients With Platelet Test Results
NCT ID: NCT02762162
Last Updated: 2019-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2007-01-31
2037-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VerifyNow French Registry
NCT00753753
Prospective/Retrospective Registry of the E-vita OPEN PLUS Stent Graft System in France
NCT04058691
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
NCT03103620
Aortic-Stent-Register
NCT01197651
Registry of AngioJet Use in the Peripheral Vascular System
NCT01086215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* a functional approach (evaluation of the antiplatelet effect of the antiplatelet regimen by multiple tests) and
* a pharmacogenomic approach (genetic profile of response to antiplatelet agents) It provides advices for specific therapeutics after identification of adverse drug interactions, treatment compliance issues and true genetic, functional or mixed resistance.
This individualized strategy allow to adjust the choice of the drugs and their optimal dosage considering the best benefit - risk ratio.
Follow up are regularly made to identify markers of MACE (major adverse cardiac event) or bleeding.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* antiplatelets testing performed as part of usual care and / or gentic profile of antiplatelet response done
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Action, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Pitie Salpetriere
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONASSIST
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.